{"name":"Lormetazepam","slug":"lormetazepam","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Methyllorazepam","N-Methyllorazepam","Loramet","Lormetazepamum","Chlorotemazepam","Wy-4082","(+-)-Lormetazepam","N05cd06","212-700-5","Noctamid"],"brands":[],"scraped":true,"has_structure":true,"cid":13314,"classes":[],"families":[{"name":"aniline","href":"/substituted/aniline"},{"name":"benzodiazepine","href":"/substituted/benzodiazepine"}],"physical":[{"label":"Molecular mass","value":"335.20 g/mol","copyable":false},{"label":"Melting point","value":"206 °C","copyable":false},{"label":"Predicted LogP","value":"2.4","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>16</sub>H<sub>12</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"7-chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-3H-1,4-benzodiazepin-2-one","copyable":true},{"label":"SMILES","value":"CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl","copyable":true},{"label":"InChI","value":"InChI=1S/C16H12Cl2N2O2/c1-20-13-7-6-9(17)8-11(13)14(19-15(21)16(20)22)10-4-2-3-5-12(10)18/h2-8,15,21H,1H3","copyable":true},{"label":"InChIKey","value":"FJIKWRGCXUCUIG-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"848-75-9","copyable":true},{"label":"UNII","value":"GU56C842ZA","copyable":true},{"label":"PubChem CID","value":"13314","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"10–12 hours","copyable":false},{"label":"Metabolism","value":"Hepatic","copyable":false},{"label":"Excretion","value":"Renal","copyable":false},{"label":"Routes of administration","value":"Oral, intravenous<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[{"name":"(R)-Lormetazepam","href":"/substance/%28r%29-lormetazepam"},{"name":"(S)-Lormetazepam","href":"/substance/%28s%29-lormetazepam"}],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N05","description":"Psycholeptics"},{"code":"N05C","description":"Hypnotics and sedatives"},{"code":"N05CD","description":"Benzodiazepine derivatives"},{"code":"N05CD06","description":""},{"code":"N05CD06","description":"Lormetazepam"}],"mesh":[{"name":"Hypnotics and Sedatives","id":"M0010885"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"GABRA1","mechanisms":["shared target"],"partners":30,"contraindicated":0},{"target":"GABRA2","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRA3","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRA4","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRA5","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRA6","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRB1","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRB2","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRB3","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRD","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRE","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRG1","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRG2","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRG3","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRP","mechanisms":["shared target"],"partners":28,"contraindicated":0},{"target":"GABRQ","mechanisms":["shared target"],"partners":28,"contraindicated":0}],"mechanism":"Lormetazepam, as a benzodiazepine, binds to the regulatory site between the α and γ subunits of γ-aminobutryic acid (GABA) A receptors with γ2 and α1, α2, α3, or α5 subunits. This facilitates the opening of the chloride channel allowing chloride ions to flow into the neuron resulting in hyperpolarization. Hyperpolarized neurons require greater simulation to reach their action potential threshold. The general inhibitory effect on neuronal depolarization produces the effects of lormetazepam.","side_effects":{"drug_id":13314,"drug_name":"lormetazepam","url":"https://sideeffects.embl.de/drugs/13314/pt","atc_codes":["N05CD06"],"side_effects":[{"name":"Aggression","cui":"C0001807"},{"name":"Amnesia","cui":"C0002622"},{"name":"Anger","cui":"C0002957"},{"name":"Rage","cui":"C0034634"},{"name":"Angioedema","cui":"C0002994"},{"name":"Anxiety","cui":"C0003467"},{"name":"Asthenia","cui":"C0004093"},{"name":"Fatigue","cui":"C0015672"},{"name":"Ataxia","cui":"C0004134"},{"name":"Abnormal behaviour","cui":"C0233514"},{"name":"Mental disorder","cui":"C0004936"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Constipation","cui":"C0009806"},{"name":"Libido decreased","cui":"C0011124"},{"name":"Disturbance in sexual arousal","cui":"C0855242"},{"name":"Delusion","cui":"C0011253"},{"name":"Depersonalisation","cui":"C0011551"},{"name":"Depression","cui":"C0011570"},{"name":"Diplopia","cui":"C0012569"},{"name":"Dizziness","cui":"C0012833"},{"name":"Dysgeusia","cui":"C0013378"},{"name":"Epilepsy","cui":"C0014544"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Gastrointestinal disorder","cui":"C0017178"},{"name":"Hallucination","cui":"C0018524"},{"name":"Headache","cui":"C0018681"},{"name":"Cardiac disorder","cui":"C0018799"},{"name":"Hyperhidrosis","cui":"C0020458"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Immune system disorder","cui":"C0021053"},{"name":"Irritability","cui":"C0022107"},{"name":"Nausea","cui":"C0027497"},{"name":"Nervous system disorder","cui":"C0027765"},{"name":"Nightmare","cui":"C0028084"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Pruritus","cui":"C0033774"},{"name":"Psychotic disorder","cui":"C0033975"},{"name":"Hyperacusis","cui":"C0034880"},{"name":"Speech disorder","cui":"C0037822"},{"name":"Withdrawal syndrome","cui":"C0038587"},{"name":"Completed suicide","cui":"C0852733"},{"name":"Suicide attempt","cui":"C0038663"},{"name":"Tachycardia","cui":"C0039231"},{"name":"Micturition disorder","cui":"C0042035"},{"name":"Urethral disorder","cui":"C0041969"},{"name":"Urinary tract disorder","cui":"C0042075"},{"name":"Urticaria","cui":"C0042109"},{"name":"Vomiting","cui":"C0042963"},{"name":"Dry mouth","cui":"C0043352"},{"name":"Agitation","cui":"C0085631"},{"name":"Drug withdrawal syndrome","cui":"C0152128"},{"name":"Muscular weakness","cui":"C0151786"},{"name":"Skin disorder","cui":"C0037274"},{"name":"Myalgia","cui":"C0231528"},{"name":"Musculoskeletal discomfort","cui":"C0948594"},{"name":"Abdominal pain upper","cui":"C0232492"},{"name":"Disturbance in attention","cui":"C0233414"},{"name":"Emotional disorder","cui":"C0233459"},{"name":"Tension","cui":"C0233494"},{"name":"Derealisation","cui":"C0233754"},{"name":"Anterograde amnesia","cui":"C0233795"},{"name":"Drug dependence","cui":"C1510472"},{"name":"Dependence","cui":"C0439857"},{"name":"Acute psychosis","cui":"C0281774"},{"name":"Altered state of consciousness","cui":"C0150450"},{"name":"Depressed level of consciousness","cui":"C0549249"},{"name":"Bradyphrenia","cui":"C0554976"},{"name":"Somnolence","cui":"C2830004"},{"name":"Visual impairment","cui":"C3665347"}],"indications":[{"name":"Distress","cui":"C0231303"},{"name":"Drug abuse","cui":"C0013146"},{"name":"Insomnia","cui":"C0917801"},{"name":"Organic brain syndrome","cui":"C0029221"},{"name":"Sleep disorder","cui":"C0851578"}]},"effects":null,"usernotes":[{"user":"bonzi","user_slug":"bonzi","external":false,"note":{"substance":"Lormetazepam","composite":false,"routes":[{"name":"Oral","dosage":"1-2mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[{"id":116013,"title":"Cocktail of Downers","author":"Wafelijzer","substances":"Olanzapine, Lormetazepam & Lorazepam","published":"2022 Jan 13","rating":null}],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"B1","act":null,"refs":[4]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"Germany","status":"Prescription only/Anlage III","act":null,"refs":[]},{"jurisdiction":"United States","status":"Schedule IV","act":"Controlled Substances Act","refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Lormetazepam"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/13314"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q186257"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB13872"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL22097"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A52993"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=848-75-9"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0041919"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D01657"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID40862442"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Lormetazepam"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/GU56C842ZA"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/13314/pt"},{"source":"Erowid","url":"https://www.erowid.org/experiences/exp_search.cgi"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 13314, Lormetazepam. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/13314>https://pubchem.ncbi.nlm.nih.gov/compound/13314</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Lormetazepam. UNII: GU56C842ZA. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GU56C842ZA>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GU56C842ZA</a>","Horowski R. Dependence liability of lormetazepam: are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures. Journal of Neural Transmission. August 2020; 127(8):1107–1115. PMID 32468272. <a href='https://doi.org/10.1007/s00702-020-02209-8'>https://doi.org/10.1007/s00702-020-02209-8</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 18:00:34","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 18:00:30","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"ok","fetched_at":"2026-11-20 18:00:36","note":null},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 18:00:30","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 18:00:30","note":"hmdb.ca refused automated access to HMDB0041919"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 18:00:32","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 18:00:28","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 18:00:30","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 18:00:30","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 18:00:30","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 18:00:30","note":null}],"description":"Lormetazepam is a  substance."}